<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: The aim of this study was to determine whether or not the coexistence of sustained ST-segment elevation and <z:mp ids='MP_0010515'>abnormal Q waves</z:mp> (STe-Q) could be a risk factor for electrical storm (ES) in implanted cardioverter defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) patients with structural <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS AND RESULTS: In <z:hpo ids='HP_0000001'>all</z:hpo>, 156 consecutive patients received <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy for secondary prevention of <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> and/or sustained ventricular tachyarrhythmias were included </plain></SENT>
<SENT sid="2" pm="."><plain>Electrical storm was defined as ≥3 separate <z:hpo ids='HP_0005141'>episodes of ventricular tachycardia</z:hpo> (VT) and/or <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>) terminated by <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapies within 24 h </plain></SENT>
<SENT sid="3" pm="."><plain>During a mean follow-up of 1825 ± 1188 days, 42 (26.9%) patients experienced ES, of whom 12 had <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo>, 15 had idiopathic <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo>, 6 had <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo>, 4 had <z:hpo ids='HP_0011663'>arrhythmogenic right ventricular cardiomyopathy</z:hpo>, 4 had <z:e sem="disease" ids="C0392077" disease_type="Disease or Syndrome" abbrv="">cardiac sarcoidosis</z:e>, and 1 had <z:hpo ids='HP_0001654'>valvular heart disease</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Sustained ST-segment elevation and <z:mp ids='MP_0010515'>abnormal Q waves</z:mp> in ≥2 leads on the 12-lead electrocardiography was observed in 33 (21%) patients </plain></SENT>
<SENT sid="5" pm="."><plain>On the Kaplan-Meier analysis, patients with STe-Q had a markedly higher risk of ES than those without STe-Q (P&lt; 0.0001) </plain></SENT>
<SENT sid="6" pm="."><plain>The multivariate Cox proportional hazards regression model indicated that STe-Q and left ventricular ejection fraction (LVEF) (&lt;30%) were independent risk factors associated with the recurrence of VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> (STe-Q: HR 1.962, 95% CI 1.24-3.12, P= 0.004; LVEF: HR 1.860, 95% CI 1.20-2.89, P= 0.006), and STe-Q was an independent risk factor associated with ES (HR 4.955, 95% CI 2.69-9.13, P&lt; 0.0001) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Sustained ST-segment elevation and <z:mp ids='MP_0010515'>abnormal Q waves</z:mp> could be a risk factor of not only recurrent VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> but also ES in patients with structural <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart diseases</z:e> </plain></SENT>
</text></document>